Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer

BACKGROUND: Thyroid cancer is the most common endocrine malignancy, and many patients with metastatic differentiated thyroid cancer (DTC), poorly differentiated thyroid cancer (PDTC), and anaplastic thyroid cancer (ATC) fail to respond to conventional therapies, resulting in morbidity and mortality....

Descripción completa

Detalles Bibliográficos
Autores principales: Morrison, Jennifer A, Pike, Laura A, Sams, Sharon B, Sharma, Vibha, Zhou, Qiong, Severson, Jill J, Tan, Aik-Choon, Wood, William M, Haugen, Bryan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995095/
https://www.ncbi.nlm.nih.gov/pubmed/24645981
http://dx.doi.org/10.1186/1476-4598-13-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995095/
https://www.ncbi.nlm.nih.gov/pubmed/24645981
http://dx.doi.org/10.1186/1476-4598-13-62

Ejemplares similares